Nuformix Technologies

Nuformix is a pharmaceutical development company that utilizes proprietary cocrystallisation technology to unlock the therapeutic potential of known drug molecules. By creating novel crystalline forms, the company improves the physical properties of existing drugs, such as solubility, stability, and delivery profiles, while securing new intellectual property. The company's primary focus is on high-value unmet needs in fibrosis and oncology, employing a lean virtual business model to progress assets to clinical proof-of-concept. Nuformix aims to out-license its optimized drug candidates to pharmaceutical partners for late-stage development and commercialization.